SL
MLAB icon

Salomon & Ludwin’s Mesa Laboratories MLAB Stock Holding History

Salomon & Ludwin’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$418 Hold
4
– – ﹤0.01% 2065
2026
Q1 		$364 Hold
4
– – ﹤0.01% 2053
2025
Q4 		$349 Hold
4
– – ﹤0.01% 2102
2025
Q3 		$293 Buy
+4
New +$288 ﹤0.01% 2103

Other funds holding MLAB

LPP
Long Path Partners Stamford, Connecticut $235M AUM 22.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Salomon & Ludwin's MLAB Position: Q2 2026 in Review

Salomon & Ludwin held its Mesa Laboratories (MLAB) position steady in Q2 2026 at 4 shares worth $418. The position accounts for ﹤0.01% of the portfolio, ranked #2065.

Salomon & Ludwin first reported a position in MLAB in Q3 2025 and has held it in 4 quarters since. 160 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

  • Salomon & Ludwin held 4 shares of Mesa Laboratories worth $418 as of Q2 2026.
  • Salomon & Ludwin left its Mesa Laboratories share count unchanged in Q2 2026.
  • Mesa Laboratories made up ﹤0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #2065 holding.
  • Salomon & Ludwin first reported a position in Mesa Laboratories in Q3 2025 and has held it in 4 quarters since.
  • 160 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.